XRAY
DENTSPLY SIRONA Inc.
-0.42 (-4.09%)9.73USD3.5M成交股數1.9B市值–本益比(近四季)0.5股價營收比-4.1%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 898M-4% | 880M+0% | 961M+1% | 904M-8% | 936M-2% | 879M-13% | 951M+0% | 984M-4% | 953M | 1.0B | 947M | 1.0B |
| 營業成本 | 405M | 453M | 518M | 463M | 446M | 413M | 456M | 473M | 447M | 490M | 452M | 478M |
| 毛利 | 493M+1% | 427M-8% | 443M-11% | 441M-14% | 490M-3% | 466M-11% | 495M0% | 511M-7% | 506M | 522M | 495M | 550M |
| 毛利率 | 54.9% | 48.5% | 46.1% | 48.8% | 52.4% | 53.0% | 52.1% | 51.9% | 53.1% | 51.6% | 52.3% | 53.5% |
| 研發費用 | 45.0M | 44.0M | 40.0M | 37.0M | 37.0M | 36.0M | 40.0M | 41.0M | 42.0M | 43.0M | 46.0M | 49.0M |
| 銷售管理費用 | 364M | 351M | 383M | 355M | 342M | 358M | 390M | 399M | 415M | 409M | 372M | 416M |
| 營業利益 | 82.0M-164% | −35.0M-156% | −139M-70% | −218M-536% | −128M-405% | 63.0M-14% | −462M+96% | 50.0M-38% | 42.0M | 73.0M | −236M | 80.0M |
| 營業利益率 | 9.1% | -4.0% | -14.5% | -24.1% | -13.7% | 7.2% | -48.6% | 5.1% | 4.4% | 7.2% | -24.9% | 7.8% |
| 稅後淨利 | 37.0M-182% | −10.0M-150% | −146M-70% | −427M+10575% | −45.0M-350% | 20.0M-70% | −494M+86% | −4.0M-105% | 18.0M | 67.0M | −266M | 86.0M |
| 淨利率 | 4.1% | -1.1% | -15.2% | -47.2% | -4.8% | 2.3% | -51.9% | -0.4% | 1.9% | 6.6% | -28.1% | 8.4% |
| 稀釋 EPS | 0.18-182% | -0.05-150% | -0.74-70% | -2.14+10600% | -0.22-344% | 0.10-69% | -2.46+97% | -0.02-105% | 0.09 | 0.32 | -1.25 | 0.40 |
| 稀釋股數 | 201M | 200M | 199M | 200M | 199M | 200M | 201M | 206M | 209M | 212M | 212M | 213M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 239M | 190M | 326M | 363M | 359M | 398M | 296M | 279M | 291M | 334M | 309M | 295M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 665M | 659M | 642M | 686M | 675M | 612M | 619M | 608M | 613M | 624M | 651M | 657M |
| 總資產 | 5.2B | 5.2B | 5.4B | 5.7B | 6.1B | 6.1B | 6.6B | 6.9B | 7.1B | 7.4B | 7.2B | 7.7B |
| 有息負債 | 2.0B | 2.0B | 2.0B | 2.0B | 2.2B | 1.6B | 1.8B | 1.7B | 1.7B | 1.8B | 1.8B | 1.8B |
| 總負債 | 3.9B | 3.9B | 4.1B | 4.2B | 4.1B | 4.0B | 4.1B | 3.8B | 3.9B | 4.1B | 3.8B | 3.9B |
| 股東權益 | 1.4B | 1.3B | 1.3B | 1.5B | 2.0B | 2.0B | 2.5B | 3.1B | 3.3B | 3.3B | 3.4B | 3.7B |
| 負債比 | 74.0% | 74.8% | 75.3% | 73.9% | 67.7% | 66.8% | 62.4% | 55.6% | 54.3% | 55.3% | 53.2% | 51.6% |
| 淨現金(現金 − 有息負債) | −1.8B | −1.8B | −1.7B | −1.7B | −1.9B | −1.2B | −1.5B | −1.5B | −1.5B | −1.5B | −1.5B | −1.5B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 40.0M+471% | – | – | – | 7.0M | – | – | 25.0M | – | – | – |
| 資本支出 | – | 52.0M | – | – | – | 19.0M | – | – | 34.0M | – | – | – |
| 自由現金流 | – | −12.0M0% | – | – | – | −12.0M | – | – | −9.0M | – | – | – |
| 折舊攤銷 | 85.0M | 79.0M | 93.0M | 92.0M | 88.0M | 79.0M | 89.0M | 86.0M | 86.0M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | 32.0M | – | – | – | 32.0M | – | – | 29.0M | – | – | – |
| 自由現金流率 | – | -1.4% | – | – | – | -1.4% | – | – | -0.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.7B
| Essential Dental Solutions | 1.5B | 39.9% | +1.0% |
|---|---|---|---|
| Connected Technology Solutions | 1.0B | 28.2% | -2.4% |
| Orthodontic And Implant Solutions | 850M | 23.1% | -12.6% |
| Wellspect Healthcare | 325M | 8.8% | +6.9% |
地區2025 年度 · 4.1B
| 歐洲 | 1.6B | 38.4% | +3.8% |
|---|---|---|---|
| 美國 | 1.2B | 28.8% | -12.3% |
| Rest Of The World | 922M | 22.5% | -0.5% |
| 德國 | 422M | 10.3% | +2.9% |
| Other Foreign 小計 | 2.1B | 50.6% | +2.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.7B | -3.0% | −598M | -16.3% | -3.00 | 104M |
| FY2024 | 3.8B | -4.3% | −910M | -24.0% | -4.48 | 281M |
| FY2023 | 4.0B | +1.1% | −132M | -3.3% | -0.62 | 228M |
| FY2022 | 3.9B | -7.3% | −950M | -24.2% | -4.41 | 368M |
| FY2021 | 4.2B | +26.7% | 411M | 9.7% | 1.87 | 515M |
| FY2020 | 3.3B | -17.0% | −73.0M | -2.2% | -0.33 | 562M |
| FY2019 | 4.0B | +0.9% | 256M | 6.4% | 1.14 | 516M |
| FY2018 | 4.0B | – | −1.0B | -25.4% | -4.51 | 317M |